Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J D'Amato

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Neurology|February 1, 1986
MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lectureS H Snyder, R J D'Amato
Lancet (London, England)|May 29, 1982
Naloxone in cerebral ischaemiaJ W Holaday, R J D'Amato
Life Sciences|January 1, 1983
Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shockJ W Holaday, R J D'Amato
Ophthalmology|August 1, 1995
Shedding light on diabetic retinopathyA P Adamis, R J D'Amato
Ophthalmology|September 1, 1995
Angiogenesis inhibition in age-related macular degenerationR J D'Amato, A P Adamis
Life Sciences|July 26, 1982
Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke"J W Holaday, R J D'Amato
Science (New York, N.Y.)|November 5, 1982
Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?J W Holaday, R J D'Amato
Nature|September 19, 1985
Predicting Parkinson's diseaseS H Snyder, R J D'Amato
Experimental Eye Research|June 1, 1997
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularizationB M Kenyon, F Browne, R J D'Amato
Journal of Neurochemistry|February 1, 1987
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelaninR J D'Amato, D F Benham, S H Snyder
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neurology|February 1, 1986
MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lectureS H Snyder, R J D'Amato
Lancet (London, England)|May 29, 1982
Naloxone in cerebral ischaemiaJ W Holaday, R J D'Amato
Life Sciences|January 1, 1983
Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shockJ W Holaday, R J D'Amato
Ophthalmology|August 1, 1995
Shedding light on diabetic retinopathyA P Adamis, R J D'Amato
Ophthalmology|September 1, 1995
Angiogenesis inhibition in age-related macular degenerationR J D'Amato, A P Adamis
Life Sciences|July 26, 1982
Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke"J W Holaday, R J D'Amato
Science (New York, N.Y.)|November 5, 1982
Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?J W Holaday, R J D'Amato
Nature|September 19, 1985
Predicting Parkinson's diseaseS H Snyder, R J D'Amato
Experimental Eye Research|June 1, 1997
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularizationB M Kenyon, F Browne, R J D'Amato
Journal of Neurochemistry|February 1, 1987
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelaninR J D'Amato, D F Benham, S H Snyder
Pageof 5